Detailed information for compound 114489

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 249.262 | Formula: C13H15NO4
  • H donors: 2 H acceptors: 3 LogP: 0.72 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(N1CCOCC1)/C=C/c1ccc(c(c1)O)O
  • InChi: 1S/C13H15NO4/c15-11-3-1-10(9-12(11)16)2-4-13(17)14-5-7-18-8-6-14/h1-4,9,15-16H,5-8H2/b4-2+
  • InChiKey: QALAKMUXMRMKIZ-DUXPYHPUSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica phosphatidylinositol 3-kinase, putative 0.0408 0.4567 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0408 0.4567 1
Echinococcus multilocularis DNA dependent protein kinase catalytic subunit 0.0789 1 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0233 0.2075 0.3536
Trichomonas vaginalis phosphatidylinositol 3-kinase class, putative 0.0312 0.3204 0.6464
Loa Loa (eye worm) hypothetical protein 0.0175 0.1246 0.1558
Entamoeba histolytica phosphatidylinositol 3-kinase, putative 0.0346 0.3678 0.7694
Trichomonas vaginalis phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative 0.0312 0.3204 0.6464
Entamoeba histolytica phosphatidylinositol 3-kinase 1, putative 0.0383 0.421 0.9073
Trypanosoma cruzi phosphatidylinositol 3-kinase vps34-like 0.0137 0.0712 0.0848
Trichomonas vaginalis phosphatidylinositol 3-kinase catalytic subunit gamma, putative 0.0408 0.4567 1
Echinococcus multilocularis phosphatidylinositol 4,5 bisphosphate 3 kinase 0.0576 0.6963 0.6168
Entamoeba histolytica hypothetical protein 0.0346 0.3678 0.7694
Brugia malayi phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative 0.0168 0.115 0.1136
Schistosoma mansoni phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K 0.0576 0.6963 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0514 0.6074 1
Trypanosoma cruzi phosphatidylinositol 3-kinase 2, putative 0.0408 0.4567 1
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.0137 0.0712 0.5
Trichomonas vaginalis phosphatidylinositol kinase, putative 0.0408 0.4567 1
Leishmania major hypothetical protein, conserved 0.0296 0.2971 0.5
Echinococcus granulosus phosphatidylinositol 45 bisphosphate 3 kinase 0.0576 0.6963 0.6168
Trichomonas vaginalis phopsphatidylinositol 3-kinase, drosophila, putative 0.0408 0.4567 1
Giardia lamblia Phosphoinositide-3-kinase, catalytic, alpha polypeptide 0.025 0.2315 1
Entamoeba histolytica phosphatidylinositol 3-kinase, putative 0.0171 0.1186 0.123
Loa Loa (eye worm) hypothetical protein 0.0233 0.2075 0.3008
Trypanosoma cruzi hypothetical protein, conserved 0.0271 0.2614 0.5363
Trypanosoma cruzi phosphatidylinositol 3-kinase 2, putative 0.0408 0.4567 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 6.1 uM Evaluated for the antioxidant property by measuring the inhibition of microsomal lipid peroxidation ChEMBL. 11206462

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.